Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-022451
Filing Date
2018-08-29
Accepted
2018-08-29 16:00:19
Documents
4
Period of Report
2018-10-01
Effectiveness Date
2018-08-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A gnpx-def14a_20181001.htm DEF 14A 568116
2 GRAPHIC gl3wrlsmluwf000002.jpg GRAPHIC 73111
3 GRAPHIC gl3wrlsmluwf000003.jpg GRAPHIC 30809
4 GRAPHIC gl3wrlsmluwf000001.jpg GRAPHIC 4873
  Complete submission text file 0001564590-18-022451.txt   719416
Mailing Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712
Business Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712 512-708-0155
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38244 | Film No.: 181044345
SIC: 2834 Pharmaceutical Preparations